圆锥角膜患者接受知觉学习训练后的视力改善:一项随机对照试验
这项随机双盲临床试验纳入9岁及以上、戴镜矫正视力0至1.0 logMAR且不耐受接触镜的非进展性圆锥角膜患者,随机分为知觉学习组与安慰剂组训练3个月。训练3个月后知觉学习组矫正远视力改善优于安慰剂组(0.17±0.15 logMAR vs 0.02±0.06 logMAR,P=0.0006),且改善至少维持6个月;作者认为知觉学习可能是矫正视力不佳的圆锥角膜患者有前景的疗法。
要点
- 训练3个月后知觉学习组CDVA改善0.17±0.15 logMAR,安慰剂组为0.02±0.06 logMAR(P=0.0006)。
- 知觉学习组17例中8例(47.06%)CDVA改善≥2行(P=0.0010)。
- 知觉学习组对比敏感度函数在中空间频率升高:3 cpd为0.11±0.17 log units,6 cpd为0.12±0.19 log units。
核心结论
- 3个月知觉学习改善了圆锥角膜患者的视力,且停止治疗3个月后改善仍维持。
- 结果表明知觉学习可能是矫正视力不佳的圆锥角膜患者有前景的疗法。
研究设计与样本
- 随机双盲临床试验,纳入9岁及以上、最佳戴镜矫正远视力0至1.0 logMAR(Snellen等效范围20/20至20/200)且不耐受接触镜的非进展性圆锥角膜患者。
- 合格受试者随机分为知觉学习组与对照组,分别接受知觉学习与安慰剂训练3个月。
- 在基线、3个月和6个月随访时测量戴镜矫正视力、对比敏感度函数、立体视锐度及视觉功能与生活质量,按意向性治疗原则分析。
主要发现
- 训练3个月后知觉学习组CDVA改善优于安慰剂组(0.17±0.15 logMAR vs 0.02±0.06 logMAR;P=0.0006)。
- 知觉学习组17例中8例(47.06%)CDVA改善≥2行(P=0.0010)。
- 与安慰剂组相比,该改善自基线起至少维持6个月(0.17±0.17 logMAR vs 0.01±0.07 logMAR;P=0.0011)。
- 知觉学习组对比敏感度函数升高主要见于中等空间频率(3 cpd为0.11±0.17 log units;6 cpd为0.12±0.19 log units)。
- 线性回归显示初始CDVA较差的患者在知觉学习后CDVA获益更好(P=0.009)。
关键数值与推荐
- 入组标准为非进展性圆锥角膜、年龄9岁及以上、最佳戴镜矫正远视力0至1.0 logMAR(Snellen等效范围20/20至20/200)且不耐受接触镜。
- 训练3个月后知觉学习组CDVA改善0.17±0.15 logMAR,安慰剂组0.02±0.06 logMAR(P=0.0006)。
- 知觉学习组17例中8例(47.06%)CDVA改善≥2行(P=0.0010)。
- 自基线起6个月时知觉学习组CDVA改善0.17±0.17 logMAR,安慰剂组0.01±0.07 logMAR(P=0.0011)。
- 对比敏感度函数升高:3 cpd为0.11±0.17 log units,6 cpd为0.12±0.19 log units。
临床怎么用
- 作者认为,知觉学习可能是矫正视力不佳的圆锥角膜患者有前景的疗法。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the effectiveness and maintenance of perceptional learning (PL) on vision improvement in keratoconus (KC) patients corrected with spectacles. DESIGN: Randomized, double-blind clinical trial. METHODS: Non-progressive KC patients 9 years of age or older who had best spectacle-corrected distance visual acuity (CDVA) of 0 to 1.0 logMAR (Snellen equivalent range 20/20 to 20/200) and who were contact lenses intolerant were enrolled. Eligible subjects were randomized into PL and control groups to receive PL and placebo training for 3 months, respectively. Spectacle-corrected visual acuity, contrast sensitivity function (CSF), stereoacuity, and visual functioning and quality of life were measured at baseline, 3 months, and 6 months of follow-up. Statistics were analyzed following the intention-to-treat principle. RESULTS: After 3 months of training, the CDVA of patients in the PL group improved as compared to the placebo group (0.17 ± 0.15 logMAR vs 0.02 ± 0.06 logMAR; P = .0006). Eight of 17 (47.06%) patients in the PL group reached CDVA improvement ≥2 lines (P = .0010). This improvement persisted for at least 6 months (from baseline) as compared to the placebo group (0.17 ± 0.17 logMAR vs 0.01 ± 0.07 logMAR; P = .0011). The increase in CSF in the PL group mainly was found for moderate spatial frequency (0.11 ± 0.17 log units at 3 cpd; 0.12 ± 0.19 log units at 6 cpd). Linear regression indicated that patients with worse initial CDVA achieved better gains in CDVA after PL (P = .009). No side effects were observed, and no subjects withdrew from the study because of training difficulties. CONCLUSIONS: Three-month PL improved vision in KC patients, and the improvement was maintained after 3 months of treatment cessation. The results indicate that PL may be a promising therapy for KC patients with unsatisfied spectacle-corrected visual acuity.
引用
- Tang XH, Wang MY, Jiang JY, et al. Vision Improvement in Keratoconus Patients Trained With Perceptual Learning: A Randomized Controlled Trial. Am J Ophthalmol. 2024. PMID: 39218388. doi:10.1016/j.ajo.2024.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。